Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.39 |
| ▸ | NPY1R | P25929 | 8/20 | 0.39 |
| ▸ | NPY2R | P49146 | 6/20 | 0.39 |
| ▸ | GNPAT | O15228 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.37 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.36 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.36 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21961850 | 0.95 | ITGB3 (0.40) | NPY4RNPY5RNPY1RNPY2RPTGS1 | |
| SCHEMBL19426417 | 0.95 | ITGB3 (0.40) | NPY4RNPY5RNPY1RNPY2RPTGS1 | |
| SCHEMBL19426331 | 0.95 | ITGB3 (0.40) | NPY4RNPY5RNPY1RNPY2RPTGS1 | |
| SCHEMBL30372208 | 0.95 | NPY4R (0.42) | NPY4RNPY5RNPY1RNPY2RPTGS1 | |
| SCHEMBL31691754 | 0.95 | NPY4R (0.42) | NPY4RNPY5RNPY1RNPY2RPTGS1 | |
| SCHEMBL29354257 | 0.93 | PTGS1 (0.41) | NPY4RNPY5RNPY1RNPY2RPTGS1 | |
| SCHEMBL30373025 | 0.92 | QRFPR (0.41) | NPY4RNPY5RNPY1RNPY2RPTGS1 | |
| SCHEMBL30372279 | 0.92 | QRFPR (0.41) | NPY4RNPY5RNPY1RNPY2RPTGS1 | |
| SCHEMBL29630595 | 0.91 | NMT1 (0.44) | NPY4RNPY5RNPY1RNPY2RPTGS1 | |
| SCHEMBL31064851 | 0.91 | GNPAT (0.44) | NPY4RNPY5RNPY1RNPY2RGNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |